Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1988 Jul;64(3):545–550.

Nature of immunological non-responsiveness to hepatitis B vaccine in healthy individuals.

S S Chiou 1, K Yamauchi 1, T Nakanishi 1, H Obata 1
PMCID: PMC1385071  PMID: 3261712

Abstract

This study was undertaken in order to analyse the immuno-regulatory mechanism of non-responsiveness to hepatitis B (HB) vaccine in healthy individuals. We have reported already that peripheral mononuclear cells (MNC) isolated from anti-HBs sero-positive subjects after booster injection are able to make anti-HBs in vitro by stimulation with pokeweed mitogen (PWM) plus HBsAg. In contrast, under the same conditions, non-responder (NR) MNC failed to produce anti-HBs in vitro, even after an additional injection, although an amount of immunoglobulin was synthesized corresponding with the responder controls. Co-culture experiments carried out with T-cell fractions (T) and non-T-cell fractions (NT) from NR and controls showed: (i) by Week 2 after the last vaccination, NT from NR could hardly be activated to produce anti-HBs; however, by Week 4 significant synthesis of anti-HBs was induced by the stimulation of responder T; (ii) in experiments using responder NT and T from NR, seven out of eight and five out of nine co-cultures were found to make anti-HBs by Weeks 2 and 4, respectively; (iii) T from NR, as well as their culture supernatants, specifically suppressed anti-HBs production of responder MNC, especially by Week 4 after the last vaccination. From these results, it is predicted that the early stage of non-responsiveness in NR is mainly due to a defect of the B-cell repertoire, while that of the late stage is caused by the existence of HBsAg-specific suppressor T cells.

Full text

PDF
545

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnaba V., Valesini G., Levrero M., Zaccari C., Van Dyke A., Falco M., Musca A., Balsano F. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients. Clin Exp Immunol. 1985 May;60(2):259–266. [PMC free article] [PubMed] [Google Scholar]
  2. Brenner M. K., Newton C. A., North M. E., Weyman C., Farrant J. The interaction of specific T-cell help and non-specific B-cell growth factors in the production of anti-tetanus antibody by human B cells grown in serum-free microcultures. Immunology. 1983 Nov;50(3):377–385. [PMC free article] [PubMed] [Google Scholar]
  3. Callard R. E., McCaughan G. W., Babbage J., Souhami R. L. Specific in vitro antibody responses by human blood lymphocytes: apparent nonresponsiveness of PBL is due to a lack of recirculating memory B cells. J Immunol. 1982 Jul;129(1):153–156. [PubMed] [Google Scholar]
  4. Callard R. E., Smith C. M. Histocompatibility requirements for T cell help in specific in vitro antibody responses to influenza virus by human blood lymphocytes. Eur J Immunol. 1981 Mar;11(3):206–212. doi: 10.1002/eji.1830110309. [DOI] [PubMed] [Google Scholar]
  5. Chang T. W., Celis E., Miller R. W., Zurawski V. R., Jr, Kung P. C. In vitro response to HBsAg of peripheral blood lymphocytes from recipients of hepatitis B vaccine. Hepatology. 1984 Sep-Oct;4(5):824–829. doi: 10.1002/hep.1840040504. [DOI] [PubMed] [Google Scholar]
  6. Chen D. S., Sung J. L., Lai M. Y. A seroepidemiologic study of hepatitis B virus infection in Taiwan. Taiwan Yi Xue Hui Za Zhi. 1978 Dec;77(12):908–918. [PubMed] [Google Scholar]
  7. Cupps T. R., Gerin J. L., Purcell R. H., Goldsmith P. K., Fauci A. S. In vitro antigen-induced antibody responses to hepatitis B surface antigen in man. Kinetic and cellular requirements. J Clin Invest. 1984 Oct;74(4):1204–1213. doi: 10.1172/JCI111529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Denes A. E., Smith J. L., Maynard J. E., Doto I. L., Berquist K. R., Finkel A. J. Hepatitis B infection in physicians. Results of a nationwide seroepidemiologic survey. JAMA. 1978 Jan 16;239(3):210–212. [PubMed] [Google Scholar]
  9. Dreesman G. R., Hollinger F. B., McCombs R. M., Melnick J. L. Production of potent anti-Australia antigen sera of high specificity and sensitivity in goats. Infect Immun. 1972 Feb;5(2):213–221. doi: 10.1128/iai.5.2.213-221.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dusheiko G. M., Hoofnagle J. H., Cooksley W. G., James S. P., Jones E. A. Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers. J Clin Invest. 1983 May;71(5):1104–1113. doi: 10.1172/JCI110860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Eder G., McDonel J. L., Dorner F. Hepatitis B vaccine. Prog Liver Dis. 1986;8:367–394. [PubMed] [Google Scholar]
  12. Grob P. J., Joller-Jemelka H. I., Binswanger U., Zaruba K., Descoeudres C., Fernex M. Interferon as an adjuvant for hepatitis B vaccination in non- and low-responder populations. Eur J Clin Microbiol. 1984 Jun;3(3):195–198. doi: 10.1007/BF02014877. [DOI] [PubMed] [Google Scholar]
  13. Lane H. C., Volkman D. J., Whalen G., Fauci A. S. In vitro antigen-induced, antigen-specific antibody production in man. Specific and polyclonal components, kinetics, and cellular requirements. J Exp Med. 1981 Oct 1;154(4):1043–1057. doi: 10.1084/jem.154.4.1043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lane H. C., Whalen G., Fauci A. S. Antigen-induced human T cell help. Precursor frequency, radiation sensitivity, and allogeneic effects. J Clin Invest. 1983 Aug;72(2):636–647. doi: 10.1172/JCI111013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lee S. D., Tong M. J. Correlation between peripheral lymphocyte subsets and antibody to hepatitis B surface antigen response in hepatitis B vaccine recipients. Scand J Infect Dis. 1985;17(3):333–335. doi: 10.3109/inf.1985.17.issue-3.15. [DOI] [PubMed] [Google Scholar]
  16. Milich D. R., Alexander H., Chisari F. V. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). III. Circumvention of nonresponsiveness in mice bearing HBsAg nonresponder haplotypes. J Immunol. 1983 Mar;130(3):1401–1407. [PubMed] [Google Scholar]
  17. Milich D. R., Chisari F. V. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). I. H-2 restriction of the murine humoral immune response to the a and d determinants of HBsAg. J Immunol. 1982 Jul;129(1):320–325. [PubMed] [Google Scholar]
  18. Moretta L., Webb S. R., Grossi C. E., Lydyard P. M., Cooper M. D. Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG. J Exp Med. 1977 Jul 1;146(1):184–200. doi: 10.1084/jem.146.1.184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Pattison C. P., Maynard J. E., Berquist D. R., Webster H. M. Epidemiology of hepatitis B in hospital personnel. Am J Epidemiol. 1975 Jan;101(1):59–64. doi: 10.1093/oxfordjournals.aje.a112071. [DOI] [PubMed] [Google Scholar]
  20. Seeff L. B., Koff R. S. Passive and active immunoprophylaxis of hepatitis B. Gastroenterology. 1984 May;86(5 Pt 1):958–981. [PubMed] [Google Scholar]
  21. Stevens R. H., Saxon A. Immunoregulation in humans: control of antitetanus toxoid antibody production after booster immunization. J Clin Invest. 1978 Dec;62(6):1154–1160. doi: 10.1172/JCI109234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Szmuness W., Stevens C. E., Harley E. J., Zang E. A., Oleszko W. R., William D. C., Sadovsky R., Morrison J. M., Kellner A. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med. 1980 Oct 9;303(15):833–841. doi: 10.1056/NEJM198010093031501. [DOI] [PubMed] [Google Scholar]
  23. Szmuness W., Stevens C. E., Zang E. A., Harley E. J., Kellner A. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology. 1981 Sep-Oct;1(5):377–385. doi: 10.1002/hep.1840010502. [DOI] [PubMed] [Google Scholar]
  24. Vento S., Hegarty J. E., Alberti A., O'Brien C. J., Alexander G. J., Eddleston A. L., Williams R. T lymphocyte sensitization to HBcAg and T cell-mediated unresponsiveness to HBsAg in hepatitis B virus-related chronic liver disease. Hepatology. 1985 Mar-Apr;5(2):192–197. doi: 10.1002/hep.1840050206. [DOI] [PubMed] [Google Scholar]
  25. Volkman D. J., Allyn S. P., Fauci A. S. Antigen-induced in vitro antibody production in humans: tetanus toxoid-specific antibody synthesis. J Immunol. 1982 Jul;129(1):107–112. [PubMed] [Google Scholar]
  26. Yamauchi K., Nakanishi T., Chiou S. S., Obata H. Suppression of hepatitis B antibody synthesis by factor made by T cells from chronic hepatitis B carriers. Lancet. 1988 Feb 13;1(8581):324–326. doi: 10.1016/s0140-6736(88)91119-1. [DOI] [PubMed] [Google Scholar]
  27. Yarchoan R., Nelson D. L. A study of the functional capabilities of human neonatal lymphocytes for in vitro specific antibody production. J Immunol. 1983 Sep;131(3):1222–1228. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES